Centogene Historical Cash Flow

CNTG Stock  USD 0.09  0.02  14.09%   
Analysis of Centogene cash flow over time is an excellent tool to project Centogene B V future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Investments of 2.4 M or Change Receivables of 0.0 as it is a great indicator of Centogene ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Centogene B V latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Centogene B V is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centogene B V. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Centogene Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Centogene balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Centogene's non-liquid assets can be easily converted into cash.

Centogene Cash Flow Chart

At this time, Centogene's Stock Based Compensation is most likely to increase significantly in the upcoming years. The Centogene's current Depreciation is estimated to increase to about 9.8 M, while Change In Cash is forecasted to increase to (15.9 M).

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Centogene B V to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Centogene operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Centogene's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Centogene B V current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centogene B V. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
At this time, Centogene's Stock Based Compensation is most likely to increase significantly in the upcoming years. The Centogene's current Depreciation is estimated to increase to about 9.8 M, while Change In Cash is forecasted to increase to (15.9 M).

Centogene cash flow statement Correlations

-0.160.56-0.11-0.870.64-0.77-0.740.810.780.56-0.59-0.360.8-0.890.840.93-0.19-0.39
-0.160.27-0.310.28-0.1-0.25-0.39-0.14-0.01-0.1-0.430.9-0.44-0.18-0.44-0.14-0.91-0.3
0.560.270.23-0.610.31-0.53-0.480.160.140.41-0.720.050.17-0.490.440.43-0.360.04
-0.11-0.310.23-0.28-0.180.440.27-0.46-0.36-0.470.25-0.21-0.10.420.31-0.130.530.85
-0.870.28-0.61-0.28-0.710.430.54-0.6-0.63-0.220.30.52-0.690.63-0.9-0.79-0.04-0.11
0.64-0.10.31-0.18-0.71-0.26-0.420.670.740.1-0.18-0.450.56-0.620.570.63-0.14-0.08
-0.77-0.25-0.530.440.43-0.260.87-0.56-0.48-0.80.75-0.08-0.40.8-0.34-0.670.590.74
-0.74-0.39-0.480.270.54-0.420.87-0.52-0.57-0.440.6-0.16-0.330.77-0.37-0.690.680.54
0.81-0.140.16-0.46-0.60.67-0.56-0.520.930.4-0.42-0.290.9-0.880.670.88-0.18-0.56
0.78-0.010.14-0.36-0.630.74-0.48-0.570.930.17-0.37-0.170.81-0.870.690.83-0.27-0.46
0.56-0.10.41-0.47-0.220.1-0.8-0.440.40.17-0.62-0.20.32-0.540.20.42-0.21-0.66
-0.59-0.43-0.720.250.3-0.180.750.6-0.42-0.37-0.62-0.34-0.350.75-0.34-0.570.60.56
-0.360.90.05-0.210.52-0.45-0.08-0.16-0.29-0.17-0.2-0.34-0.480.02-0.52-0.29-0.72-0.27
0.8-0.440.17-0.1-0.690.56-0.4-0.330.90.810.32-0.35-0.48-0.740.860.890.17-0.31
-0.89-0.18-0.490.420.63-0.620.80.77-0.88-0.87-0.540.750.02-0.74-0.64-0.890.50.64
0.84-0.440.440.31-0.90.57-0.34-0.370.670.690.2-0.34-0.520.86-0.640.830.230.04
0.93-0.140.43-0.13-0.790.63-0.67-0.690.880.830.42-0.57-0.290.89-0.890.83-0.18-0.41
-0.19-0.91-0.360.53-0.04-0.140.590.68-0.18-0.27-0.210.6-0.720.170.50.23-0.180.58
-0.39-0.30.040.85-0.11-0.080.740.54-0.56-0.46-0.660.56-0.27-0.310.640.04-0.410.58
Click cells to compare fundamentals

Centogene Account Relationship Matchups

Centogene cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory(463K)(9.6M)5.7M2.1M(852.2K)(894.8K)
Investments14.2M(16.2M)(5.4M)(733K)2.3M2.4M
Change In Cash31.9M7.1M(30.3M)18.1M(16.7M)(15.9M)
Net Borrowings338K(14.4M)(7.3M)(2.9M)(2.6M)(2.8M)
Stock Based Compensation6.4M5.7M8.0M(16K)2.9M4.2M
Free Cash Flow(15.4M)(8.1M)(27.4M)(28.6M)(39.2M)(37.2M)
Change In Working Capital(900K)4.6M(7.1M)(6.2M)(4.8M)(4.6M)
Begin Period Cash Flow9.2M41.1M48.2M17.8M35.9M21.5M
Total Cashflows From Investing Activities(8.7M)14.2M(16.2M)(5.4M)(6.2M)(6.5M)
Other Cashflows From Financing Activities(1.3M)(248K)(267K)(2.1M)(6.0M)(5.7M)
Depreciation6.6M15.1M21.3M10.4M7.5M9.8M
Other Non Cash Items(375K)479K(14K)1.1M15.2M16.0M
Capital Expenditures7.6M16.5M5.7M2.1M2.2M2.1M
Total Cash From Operating Activities(7.8M)8.5M(21.7M)(26.5M)(37.0M)(35.1M)
Change To Account Receivables(5.7M)(15.2M)5.0M6.8M(3.6M)(3.7M)
Change To Operating Activities635K2.1M6.5M3.5M4.0M2.3M
Net Income(20.7M)(21.1M)(46.9M)(31.7M)(34.8M)(36.5M)
Total Cash From Financing Activities25.5M14.8M(3.2M)46.3M18.6M20.2M
End Period Cash Flow41.1M48.2M17.8M36.0M19.1M24.1M
Other Cashflows From Investing Activities3.1M451K396K171K153.9K146.2K
Change To Netincome5.3M7.4M10.2M10.3M11.9M6.6M
Change To Liabilities3.1M24.0M(20.5M)(4.9M)(4.4M)(4.2M)

Currently Active Assets on Macroaxis

When determining whether Centogene B V is a strong investment it is important to analyze Centogene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Centogene's future performance. For an informed investment choice regarding Centogene Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centogene B V. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centogene. If investors know Centogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.39)
Revenue Per Share
1.723
Quarterly Revenue Growth
(0.08)
Return On Assets
(0.27)
Return On Equity
(13.75)
The market value of Centogene B V is measured differently than its book value, which is the value of Centogene that is recorded on the company's balance sheet. Investors also form their own opinion of Centogene's value that differs from its market value or its book value, called intrinsic value, which is Centogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centogene's market value can be influenced by many factors that don't directly affect Centogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Centogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.